New Zealand Heart Valve Study
- 400 participants
- 6 sites in New Zealand
To determine whether natriuretic peptides are a reliable and clinically useful non-invasive marker of severity, progression, and left ventricular remodelling in aortic valve disease. 3 year follow-up. Sample size 400 patients.